The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

about

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

Item

http://www.wikidata.org/entity/Q36394266

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

@ast

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

@en

type

Item

label

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

@ast

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

@en

prefLabel

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

@ast

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

@en

P1476

The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.

@en

P2093

A Damiani

http://www.w3.org/2001/XMLSchema#string

F Li Gobbi

http://www.w3.org/2001/XMLSchema#string

M Benucci

http://www.w3.org/2001/XMLSchema#string

M Infantino

http://www.w3.org/2001/XMLSchema#string

M Manfredi

http://www.w3.org/2001/XMLSchema#string

V Grossi

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the nucleosome core particle at 2.8 A resolution

Lupus nephritis: the central role of nucleosomes revealed

Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.

The key role of nucleosomes in lupus.

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

The role of nucleosomes in lupus.

P304

961203317709344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203317709344

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28587585

http://www.w3.org/2001/XMLSchema#string